Not currently recruiting at University of California Health
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream With Phototherapy in Participants With Vitiligo
Summary
- Eligibility
- for people ages 12-99 (full criteria)
- Location
- at UC Davis
- Dates
- study startedestimated completion
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients at some sites,
but this study is not currently recruiting here - Start Date
- Completion Date
- (estimated)
- Sponsor
- Incyte Corporation
- ID
- NCT05247489
- Phase
- Phase 2 research study
- Study Type
- Interventional
- Participants
- Expecting 50 study participants
- Last Updated